Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
123I-Methyljodbenzylguanidin- (MIBG-) Szintigraphie: Paradoxe Nuklidspeicherung eines onkozytären Nebennierenrindenkarzinoms.
Padberg B, Rordorf T, Suter S, Pfeiffer D, Wild D, Schröder S. 123I-Methyljodbenzylguanidin- (MIBG-) Szintigraphie: Paradoxe Nuklidspeicherung eines onkozytären Nebennierenrindenkarzinoms. Pathologe 2007; 28:281-4.
01.07.2007123I-Methyljodbenzylguanidin- (MIBG-) Szintigraphie: Paradoxe Nuklidspeicherung eines onkozytären Nebennierenrindenkarzinoms.
01.07.2007Pathologe 2007; 28:281-4
Padberg B-C, Rordorf Tamara, Suter S, Pfeiffer D, Wild D, Schröder Stephan
Riniker S, Köberle D. (Neo-) Adjuvante Therapien des Rektumkarzinoms: Neue Strategien
Riniker S. Riniker S, Köberle D. (Neo-) Adjuvante Therapien des Rektumkarzinoms: Neue Strategien. Schweizer Zeitschrift für Onkologie 2007; 3:25-28.
29.06.2007Riniker S, Köberle D. (Neo-) Adjuvante Therapien des Rektumkarzinoms: Neue Strategien
29.06.2007Schweizer Zeitschrift für Onkologie 2007; 3:25-28
Riniker Salome
Intra-operative sonography: a valuable aid during breast-conserving surgery for occult breast cancer
Haid A, Wenzl E, Haid B, Toeppker M, Schuster A, Köberle-Wührer R, Jasarevic Z, Dunzinger S, Knauer M, Offner F. Intra-operative sonography: a valuable aid during breast-conserving surgery for occult breast cancer. Ann Surg Oncol 2007; 14:3090-101.
26.06.2007Intra-operative sonography: a valuable aid during breast-conserving surgery for occult breast cancer
26.06.2007Ann Surg Oncol 2007; 14:3090-101
Haid Anton, Wenzl Etienne, Haid Bernhard, Toeppker Michael, Schuster Antonius, Köberle-Wührer Roswitha, Jasarevic Zerina, Dunzinger Stephanie, Knauer Michael, Offner Felix
Spontaneous, multifocal cervical liquor leakage causing an intracranial hypotension syndrome
Frizsche D, Burkhardt C, Hundsberger T, Tettenborn B (2007). Spontaneous, multifocal cervical liquor leakage causing an intracranial hypotension syndrome.
08.06.2007Spontaneous, multifocal cervical liquor leakage causing an intracranial hypotension syndrome
08.06.2007-
Frizsche D, Burkhardt C, Hundsberger Thomas, Tettenborn Barbara
Fatal outcome in a patient suffering from statin-induced rhabdomyolysis, hypothyroidism and inclusion body myopathy
Wunnicke K, Nitschke S, Hundsberger T, Tolnay M, Tettenborn B (2007). Fatal outcome in a patient suffering from statin-induced rhabdomyolysis, hypothyroidism and inclusion body myopathy.
08.06.2007Fatal outcome in a patient suffering from statin-induced rhabdomyolysis, hypothyroidism and inclusion body myopathy
08.06.2007-
Wunnicke K, Nitschke S, Hundsberger Thomas, Tolnay M, Tettenborn Barbara
A new approach for distinguishing cathepsin E and D activity in antigen-processing organelles
Zaidi N, Herrmann T, Baechle D, Schleicher S, Gogel J, Driessen C, Voelter W, Kalbacher H. A new approach for distinguishing cathepsin E and D activity in antigen-processing organelles. The FEBS journal 2007; 274:3138-49.
01.06.2007A new approach for distinguishing cathepsin E and D activity in antigen-processing organelles
01.06.2007The FEBS journal 2007; 274:3138-49
Zaidi Nousheen, Herrmann Timo, Baechle Daniel, Schleicher Sabine, Gogel Jeannette, Driessen Christoph, Voelter Wolfgang, Kalbacher Hubert
Increased pulmonary FDG uptake in bleomycin-associated pneumonitis
von Rohr L, Klaeser B, Jörger M, Kluckert T, Cerny T, Gillessen Sommer S. Increased pulmonary FDG uptake in bleomycin-associated pneumonitis. Onkologie 2007; 30:320-3.
01.06.2007Increased pulmonary FDG uptake in bleomycin-associated pneumonitis
01.06.2007Onkologie 2007; 30:320-3
von Rohr Lukas, Klaeser Bernd, Jörger Markus, Kluckert Thomas, Cerny Thomas, Gillessen Sommer Silke
The desire for hastened death in patients with metastatic cancer
Rodin G, Zimmermann C, Rydall A, Jones J, Shepherd F, Moore M, Früh M, Donner A, Gagliese L. The desire for hastened death in patients with metastatic cancer. Journal of pain and symptom management 2007; 33:661-75.
01.06.2007The desire for hastened death in patients with metastatic cancer
01.06.2007Journal of pain and symptom management 2007; 33:661-75
Rodin Gary, Zimmermann Camilla, Rydall Anne, Jones Jennifer, Shepherd Frances A, Moore Malcolm, Früh Martin, Donner Allan, Gagliese Lucia
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
Herrmann R, Stemmer S, Tàmas K, Kornek G, Köberle D, Cina S, Bernhard J, Dietrich D, Scheithauer W, Swiss Group for Clinical Cancer Research, Mingrone W, Köhne C, Bodoky G, Ruhstaller T, Glimelius B, Bajetta E, Schüller J, Saletti P, Bauer J, Figer A, Pestalozzi B, Central European Cooperative Oncology Group. Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007; 25:2212-7.
01.06.2007Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
01.06.2007Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007; 25:2212-7
Herrmann Richard, Stemmer Salomon M, Tàmas Karin, Kornek Gabriela V, Köberle Dieter, Cina Susanne, Bernhard Jürg, Dietrich Daniel, Scheithauer Werner, Swiss Group for Clinical Cancer Research, Mingrone Walter, Köhne Claus-Henning, Bodoky György, Ruhstaller Thomas, Glimelius Bengt, Bajetta Emilio, Schüller Johannes, Saletti Piercarlo, Bauer Jean, Figer Arie, Pestalozzi Bernhard, Central European Cooperative Oncology Group
Macrocytosis and cobalamin deficiency in patients treated with sunitinib
Gillessen Sommer S, Graf L, Korte W, Cerny T. Macrocytosis and cobalamin deficiency in patients treated with sunitinib. The New England journal of medicine 2007; 356:2330-1.
31.05.2007Macrocytosis and cobalamin deficiency in patients treated with sunitinib
31.05.2007The New England journal of medicine 2007; 356:2330-1
Gillessen Sommer Silke, Graf Lukas, Korte Wolfgang, Cerny Thomas
The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer
Karlsson P, Goldhirsch A, Gelber R, Forbes J, Crivellari D, Thürlimann B, Fey M, Holmberg S, Collins J, Lindtner J, Murray E, Gusterson B, Castiglione-Gertsch M, Coates A, Price K, Cole B, Wallgren A. The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. JCO 2007; 25:2019-26.
20.05.2007The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer
20.05.2007JCO 2007; 25:2019-26
Karlsson Per, Goldhirsch Aron, Gelber Richard D, Forbes John F, Crivellari Diana, Thürlimann Beat, Fey Martin F, Holmberg Stig B, Collins John P, Lindtner Jurij, Murray Elizabeth, Gusterson Barry A, Castiglione-Gertsch Monica, Coates Alan S, Price Karen N, Cole Bernard F, Wallgren Arne
Therapy refractory Voltage-gated potassium channel antibody (VGKC-Ab) negative neuromyotonia with generalized lymphadenopathy
Nitschke S, Hundsberger T, Hägele-Link S, Tettenborn B. Therapy refractory Voltage-gated potassium channel antibody (VGKC-Ab) negative neuromyotonia with generalized lymphadenopathy. S C H W E I Z E R A R C H I V F Ü R N E U R O L O G I E U N D P S Y C H I A T R I E 2007; 158
13.05.2007Therapy refractory Voltage-gated potassium channel antibody (VGKC-Ab) negative neuromyotonia with generalized lymphadenopathy
13.05.2007S C H W E I Z E R A R C H I V F Ü R N E U R O L O G I E U N D P S Y C H I A T R I E 2007; 158
Nitschke S, Hundsberger Thomas, Hägele-Link Stefan, Tettenborn Barbara
Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro
Burster T, Tolosa E, Overkleeft H, Kalbacher H, Youssef S, Boehm B, Falk K, Roetzschke O, Reich M, Baechle D, Øren A, Poeschel S, Beck A, Driessen C. Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro. Immunology 2007; 121:82-93.
01.05.2007Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro
01.05.2007Immunology 2007; 121:82-93
Burster Timo, Tolosa Eva, Overkleeft Herman, Kalbacher Hubert, Youssef Sawsan, Boehm Bernhard O, Falk Kirsten, Roetzschke Olaf, Reich Michael, Baechle Daniel, Øren Anita, Poeschel Simone, Beck Alexander, Driessen Christoph
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial
Mauriac L, Castiglione-Gertsch M, Price K, Coates A, Smith I, Viale G, Rabaglio M, Zabaznyi N, Goldhirsch A, BIG 1-98 Collaborative Group, Gelber R, Nogaret J, Keshaviah A, Debled M, Mouridsen H, Forbes J, Thürlimann B, Paridaens R, Monnier A, Láng I, Wardley A, International Breast Cancer Study Group. Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Ann Oncol 2007; 18:859-67.
01.05.2007Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial
01.05.2007Ann Oncol 2007; 18:859-67
Mauriac L, Castiglione-Gertsch M, Price K N, Coates A S, Smith I, Viale G, Rabaglio M, Zabaznyi N, Goldhirsch A, BIG 1-98 Collaborative Group, Gelber R D, Nogaret J-M, Keshaviah A, Debled M, Mouridsen H, Forbes J F, Thürlimann Beat, Paridaens R, Monnier A, Láng I, Wardley A, International Breast Cancer Study Group
The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma.
Horger M, Kanz L, Denecke B, Vonthein R, Pereira P, Claussen C, Driessen C. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma. Cancer 2007; 109:1617-26.
15.04.2007The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma.
15.04.2007Cancer 2007; 109:1617-26
Horger Marius, Kanz Lothar, Denecke Barbara, Vonthein Reinhard, Pereira Philippe, Claussen Claus Detlef, Driessen Christoph
Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cell-penetrating peptides mediate nonselective transport to cysteine cathepsins
Reich M, van Swieten P, Sommandas V, Kraus M, Fischer R, Weber E, Kalbacher H, Overkleeft H, Driessen C. Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cell-penetrating peptides mediate nonselective transport to cysteine cathepsins. Journal of leukocyte biology 2007; 81:990-1001.
01.04.2007Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cell-penetrating peptides mediate nonselective transport to cysteine cathepsins
01.04.2007Journal of leukocyte biology 2007; 81:990-1001
Reich Michael, van Swieten Paul F, Sommandas Vinod, Kraus Marianne, Fischer Rainer, Weber Ekkehard, Kalbacher Hubert, Overkleeft Herman S, Driessen Christoph
The Experience of God in Suffering and Dying
Renz M. The Experience of God in Suffering and Dying. The Way. A Journal of Contemporary Spirituality publ. by the British Jesuits 2007; 46:59-74.
01.04.2007The Experience of God in Suffering and Dying
01.04.2007The Way. A Journal of Contemporary Spirituality publ. by the British Jesuits 2007; 46:59-74
Renz Monika
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials
Keshaviah A, Coates A, Gelber R, Castiglione Gertsch M, Simoncini E, Pagani O, Price K, Aebi S, Mendiola C, Thürlimann B, Colleoni M, Collins J, Crivellari D, Lindtner J, Rotmensz N, Dellapasqua S, Goldhirsch A. CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials. Ann Oncol 2007; 18:701-8.
01.04.2007CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials
01.04.2007Ann Oncol 2007; 18:701-8
Keshaviah A, Coates A S, Gelber R D, Castiglione Gertsch M, Simoncini E, Pagani O, Price K N, Aebi S, Mendiola C, Thürlimann Beat, Colleoni M, Collins J, Crivellari D, Lindtner J, Rotmensz N, Dellapasqua S, Goldhirsch A
Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study
Rupp U, Sohn C, Sinn H, Huober J, Hanft G, Staab A, Schmidt P, Lauschner I, Schuetz F, Eichbaum M, Schoendorf-Holland E, Schneeweiss A. Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study. Anti-cancer drugs 2007; 18:477-85.
01.04.2007Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study
01.04.2007Anti-cancer drugs 2007; 18:477-85
Rupp Ute, Sohn Christof, Sinn Hans-Peter, Huober Jens, Hanft Gertraud, Staab Alexander, Schmidt Peter, Lauschner Ilka, Schuetz Florian, Eichbaum Michael, Schoendorf-Holland Eva, Schneeweiss Andreas
Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)
Wagner U, Jackisch C, Meier W, Schmalfeldt B, Stähle A, Gropp M, Sehouli J, Lück H, Loibl S, Huober J, Pfisterer J, du Bois A, AGO Ovarian Cancer Study Group. Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6). Gynecologic oncology 2007; 105:132-7.
01.04.2007Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)
01.04.2007Gynecologic oncology 2007; 105:132-7
Wagner Uwe, Jackisch Christian, Meier Werner, Schmalfeldt Barbara, Stähle Anne, Gropp Martina, Sehouli Jalid, Lück Hans-Joachim, Loibl Sybille, Huober Jens, Pfisterer Jacobus, du Bois Andreas, AGO Ovarian Cancer Study Group